Kirsi M. Talala
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC).
Journal: BJU international
Published: July 04, 2026
Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The 'Good', the 'Bad', and the 'Ugly' After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer.
Journal: European urology open science
Published: June 14, 2026
Comparison of the Swedish and Finnish Centers in the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Journal: European urology open science
Published: April 19, 2026
European Study of Prostate Cancer Screening - 23-Year Follow-up.
Journal: The New England journal of medicine
Published: October 29, 2025
Effects of Causal and Noncausal Components of Screening on Prostate Cancer Mortality: A Mediation Analysis from the Dutch, Finnish, and Swedish Centers of the European Randomized Study of Screening for Prostate Cancer.
Journal: European urology oncology
Published: September 29, 2025
Model-based trends in the estimated number of children affected by maternal cancer diagnosis or death in Finland in 1968-2022.
Journal: Acta oncologica (Stockholm, Sweden)
Published: June 04, 2025
Association of prostate-specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result.
Journal: BJU international
Published: January 22, 2025
Risk factors for low-risk prostate cancer: A retrospective cohort study within the FinRSPC trial.
Journal: International journal of cancer
Published: December 18, 2024
SNP genotypes in CYP2C9 and VKORC1 genes do not affect prostate cancer or cancer mortality among warfarin users in Finnish prostate cancer patients.
Journal: PloS one
Published: November 14, 2024
Do differences in secondary treatment explain mortality impact of prostate cancer screening? - A randomized screening trial.
Journal: Urologic oncology
Published: October 13, 2024
Long-term Risk of Prostate Cancer Mortality Among Men with Baseline Prostate-specific Antigen Below 3 ng/ml: Evidence from the Finnish Randomized Study of Screening for Prostate Cancer.
Journal: European urology oncology
Published: August 17, 2024
Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer.
Journal: BJU international
Published: May 10, 2024
Last Updated: 09/26/2026